HeartBeam, Inc. (BEAT) company profile

HeartBeam is a medical technology company that develops ambulatory cardiac monitoring solutions designed for use outside clinical environments. The company's primary offering is the HeartBeam System, a cable-free cardiac monitoring platform comprising a credit-card-sized three-dimensional electrocardiogram (ECG) recording device, a patient mobile application, cloud-based algorithms, and a web-based physician portal. The system records electrical signals from the heart across three dimensions to synthesize twelve-lead ECG readings for remote arrhythmia assessment, supported by continuous access to on-demand cardiologists. Target customers include concierge physicians, preventive cardiology practices, and hospital cardiology departments.

The company operates primarily within the United States, targeting initial commercialization through select cardiology practices and direct sales channels, while exploring potential international expansion opportunities. HeartBeam employed 16 personnel as of late 2025, expanding to 17 staff members in early 2026. The provided text does not disclose the company's specific headquarters location.

Summary of the business section of HeartBeam's latest annual report, written by StockData.

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

“As of December 31, 2025, we had 16 employees.”